Your browser doesn't support javascript.
loading
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV.
Ghofrani, Joshua; Bowen, Allan; Chen, Jie; Balakrishnan, Preethi Bala; Powell, Allison B; Cherukula, Kondareddy; Cruz, Conrad Russell Y; Jones, R Brad; Lynch, Rebecca M; Sweeney, Elizabeth E; Fernandes, Rohan.
Affiliation
  • Ghofrani J; The Institute for Biomedical Sciences, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.
  • Bowen A; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Chen J; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Balakrishnan PB; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Powell AB; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Cherukula K; The Institute for Biomedical Sciences, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.
  • Cruz CRY; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Jones RB; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Lynch RM; The George Washington Cancer Center, The George Washington University, Washington, DC, USA.
  • Sweeney EE; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Fernandes R; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Int J Nanomedicine ; 18: 4055-4066, 2023.
Article in En | MEDLINE | ID: mdl-37520301

Full text: 1 Database: MEDLINE Main subject: HIV Infections / HIV-1 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Nanomedicine Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: HIV Infections / HIV-1 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Nanomedicine Year: 2023 Type: Article Affiliation country: United States